Literature DB >> 21940480

Comparison of the INNO-LiPA and PapType assays for detection of human papillomavirus in archival vulva dysplasia and/or neoplasia tissue biopsy specimens.

Sarah E Tan1, Suzanne M Garland, Alice R Rumbold, Sepehr N Tabrizi.   

Abstract

INNO-LiPA and PapType human papillomavirus (HPV) genotyping assays were compared for detection of HPV genotypes on archival vulvar tissue. The INNO-LiPA assay detected 49 HPV-16 infections, compared with 47 detected by the PapType assay. The INNO-LiPA assay detected amplifiable DNA in 59 (91%) biopsy specimens, compared with 57 (88%) specimens for which amplifiable DNA was detected by the PapType assay. The two genotyping assays were highly comparable.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21940480      PMCID： PMC3209107          DOI： 10.1128/JCM.00516-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

Review 1.  Tissue handling for genome-wide expression analysis: a review of the issues, evidence, and opportunities.

Authors:  Fabiola Medeiros; C Ted Rigl; Glenda G Anderson; Shawn H Becker; Kevin C Halling
Journal:  Arch Pathol Lab Med       Date:  2007-12       Impact factor: 5.534

2.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

3.  Human papillomavirus genotyping using archival vulval dysplastic or neoplastic biopsy tissues: comparison between the INNO-LiPA and linear array assays.

Authors:  Sarah E Tan; Suzanne M Garland; Alice R Rumbold; Sepehr N Tabrizi
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

4.  Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test.

Authors:  Dennis van Hamont; Maaike A P C van Ham; Judith M J E Bakkers; Leon F A G Massuger; Willem J G Melchers
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

5.  The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN).

Authors:  Monica Srodon; Mark H Stoler; Gwen B Baber; Robert J Kurman
Journal:  Am J Surg Pathol       Date:  2006-12       Impact factor: 6.394

6.  Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years.

Authors:  B Romanowski; P Colares de Borba; P S Naud; C M Roteli-Martins; N S De Carvalho; J C Teixeira; F Aoki; B Ramjattan; R M Shier; R Somani; S Barbier; M M Blatter; C Chambers; D Ferris; S A Gall; F A Guerra; D M Harper; J A Hedrick; D C Henry; A P Korn; R Kroll; A-B Moscicki; W D Rosenfeld; B J Sullivan; C S Thoming; S K Tyring; C M Wheeler; G Dubin; A Schuind; T Zahaf; Mary Greenacre; An Sgriobhadair
Journal:  Lancet       Date:  2009-12-12       Impact factor: 79.321

7.  Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Authors:  Suzanne M Garland; Mauricio Hernandez-Avila; Cosette M Wheeler; Gonzalo Perez; Diane M Harper; Sepp Leodolter; Grace W K Tang; Daron G Ferris; Marc Steben; Janine Bryan; Frank J Taddeo; Radha Railkar; Mark T Esser; Heather L Sings; Micki Nelson; John Boslego; Carlos Sattler; Eliav Barr; Laura A Koutsky
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

8.  HPV DNA in intraepithelial neoplasia and carcinoma of the vulva and penis.

Authors:  G Della Torre; R Donghi; A Longoni; S Pilotti; G Pasquini; G De Palo; M A Pierotti; F Rilke; G Della Porta
Journal:  Diagn Mol Pathol       Date:  1992-03

9.  Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis.

Authors:  Hugo De Vuyst; Gary M Clifford; Maria Claudia Nascimento; Margaret M Madeleine; Silvia Franceschi
Journal:  Int J Cancer       Date:  2009-04-01       Impact factor: 7.396

Review 10.  Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors.

Authors:  Jennifer S Smith; Danielle M Backes; Brooke E Hoots; Robert J Kurman; Jeanne M Pimenta
Journal:  Obstet Gynecol       Date:  2009-04       Impact factor: 7.661
View more
  5 in total

1.  Comparison of PapType to Digene Hybrid Capture 2, Roche linear array, and Amplicor for detection of high-risk human papillomavirus genotypes in women with previous abnormal pap smears.

Authors:  Sepehr N Tabrizi; Matthew P Stevens; Zaheer A Khan; Conan Chow; Martin A Devitt; Suzanne M Garland
Journal:  J Clin Microbiol       Date:  2012-05-30       Impact factor: 5.948

2.  Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions.

Authors:  Jack Cuzick; Linda Ho; George Terry; Michelle Kleeman; Michael Giddings; Janet Austin; Louise Cadman; Lesley Ashdown-Barr; Maria J Costa; Anne Szarewski
Journal:  J Clin Virol       Date:  2014-02-14       Impact factor: 3.168

3.  Human papillomavirus type 6 and 11 genetic variants found in 71 oral and anogenital epithelial samples from Australia.

Authors:  Jennifer A Danielewski; Suzanne M Garland; Jenny McCloskey; Richard J Hillman; Sepehr N Tabrizi
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

4.  A case-control study of the role of human papillomavirus in oesophageal squamous cell carcinoma in australia.

Authors:  Surabhi S Liyanage; Eva Segelov; Aisha Malik; Suzanne M Garland; Sepehr N Tabrizi; Eleanor Cummins; Holly Seale; Bayzidur Rahman; Aye Moa; Andrew P Barbour; Philip J Crowe; C Raina MacIntyre
Journal:  J Oncol       Date:  2014-04-28       Impact factor: 4.375

5.  Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methods.

Authors:  Felipe A Castro; Jill Koshiol; Wim Quint; Cosette M Wheeler; Maura L Gillison; Laurence M Vaughan; Bernhard Kleter; Leen-Jan van Doorn; Anil K Chaturvedi; Allan Hildesheim; Mark Schiffman; Sophia S Wang; Rosemary E Zuna; Joan L Walker; S Terence Dunn; Nicolas Wentzensen
Journal:  BMC Infect Dis       Date:  2015-11-25       Impact factor: 3.090
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.